Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048. - Rischin, Danny; Harrington, Kevin J.; Greil, Richard; Soulières, Denis; Tahara, Makoto; de Castro Jr, Gilberto; Psyrri, Amanda; Braña, Irene; Neupane, Prakash; Bratland, Åse; Fuereder, Thorsten; Hughes, Brett G.M.; et al. (Oral Oncology, 2022)